Cefa-Drops
Category
Cefa-Drops Brand names, Cefa-Drops Analogs
Cefa-Drops Brand Names Mixture
Cefa-Drops Chemical_Formula
C16H17N3O5S
Cefa-Drops RX_link
http://www.rxlist.com/cgi/generic/cefadrox.htm
Cefa-Drops fda sheet
Cefa-Drops msds (material safety sheet)
Cefa-Drops Synthesis Reference
L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)
Cefa-Drops Molecular Weight
363.389 g/mol
Cefa-Drops Melting Point
197oC
Cefa-Drops H2O Solubility
1110 mg/L
Cefa-Drops State
Solid
Cefa-Drops LogP
-0.355
Cefa-Drops Dosage Forms
Capsule; Tablet; Oral liquid
Cefa-Drops Indication
For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes
Cefa-Drops Pharmacology
Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.
Cefa-Drops Absorption
Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.
Cefa-Drops Toxicity
Nausea, vomiting, diarrhoea, allergic rashes may occur
Cefa-Drops Patient Information
Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial
infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial
infection, patients should be told that although it is common to feel better early in the course of therapy, the
medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1)
decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop
resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.
Cefa-Drops Organisms Affected
Enteric bacteria and other eubacteria
